Hassan Argani
Overview
Explore the profile of Hassan Argani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
82
Citations
690
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Argani H
Exp Clin Transplant
. 2024 Nov;
22(Suppl 5):3-12.
PMID: 39498912
Clear guidelines for therapeutic apheresis in children after renal transplant do not exist. This article reviews the current experiences with therapeutic apheresis in pediatric transplant recipients. The ideal characteristics of...
2.
Argani H
Exp Clin Transplant
. 2024 Feb;
22(Suppl 1):60-65.
PMID: 38385374
Renal transplant is the best procedure for patients with end-stage renal disease. Although an ideal kidney transplant should survive for the lifetime of each recipient, there may be a need...
3.
Danaiyan S, Mesgari Abbasi M, Raeisi S, Argani H, Ghorbanihaghjo A, Shanehbandi D, et al.
Appl Biochem Biotechnol
. 2023 May;
196(2):632-642.
PMID: 37166648
Remdesivir (REM) and dexamethasone (DEX) both have been used to treat coronavirus disease 2019 (COVID-19). The present study aimed to evaluate the effects of REM and DEX on kidney structure...
4.
Javidi M, Ahmadizad S, Argani H, Najafi A, Ebrahim K, Salehi N, et al.
J Cardiovasc Dev Dis
. 2022 Sep;
9(9).
PMID: 36135432
This study compared the effects of lower- versus higher-intensity isometric handgrip exercise on resting blood pressure (BP) and associated clinical markers in adults with hypertension. Thirty-nine males were randomly assigned...
5.
Argani H
Exp Clin Transplant
. 2022 Aug;
20(Suppl 4):13-19.
PMID: 36018014
The expanded criteria donor is any donor over the age of 60 years or a donor over the age of 50 years with 2 of the following 3 items: (1)...
6.
Argani H
Exp Clin Transplant
. 2022 May;
20(Suppl 3):21-26.
PMID: 35570595
The wait list for organ transplant exceeds the rate of organ donation, especially in children. The solid-organ transplant rate has remained stable over time, despite increased demand. Although donation after...
7.
Fakharzadeh S, Kalanaky S, Argani H, Dadashzadeh S, Torbati P, Nazaran M, et al.
Drug Dev Res
. 2020 Nov;
82(3):393-403.
PMID: 33230842
Metal-Organic Frameworks (MOFs) are a new class of crystalline porous structures which can be used as a novel structure in diverse fields of medical science. Several studies have shown that...
8.
Fakharzadeh S, Argani H, Torbati P, Dadashzadeh S, Kalanaky S, Nazaran M, et al.
J Trace Elem Med Biol
. 2020 May;
61:126547.
PMID: 32460199
Background: The growing morbidity and mortality rate of chronic kidney disease (CKD) has forced researchers to find more efficient strategies for controlling this disease. Studies have proven the important role...
9.
Jabarpour M, Rashtchizadeh N, Ghorbani Haghjo A, Argani H, Nemati M, Dastmalchi S, et al.
Iran J Basic Med Sci
. 2020 May;
23(2):206-213.
PMID: 32405364
Objectives: Hypercholesterolemia is a common metabolic disorder in developing and developed countries and is associated with the increased rates of chronic kidney disease (CKD). Statin therapy could reduce cholesterol synthesis...
10.
Fakharzadeh S, Argani H, Dadashzadeh S, Kalanaky S, Torbati P, Nazaran M, et al.
Diabetes Metab Syndr Obes
. 2020 May;
13:1179-1188.
PMID: 32368111
Background: One common feature of chronic diseases, such as cancer, diabetes and chronic kidney disease (CKD), is the disruption of iron metabolism and increase in labile iron pool, which can...